Lumasiran
ALN-GO1-008
Phase 2 small_molecule terminated
Quick answer
Lumasiran for Recurrent Calcium Oxalate Kidney Stone Disease is a Phase 2 program (small_molecule) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Indication
- Recurrent Calcium Oxalate Kidney Stone Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated